92531-11-8 Usage
Uses
Used in Organic Synthesis:
Toluene-4-sulfonic acid 1-acetyl-piperidin-4-yl ester is used as a reagent in organic synthesis for the production of various pharmaceuticals, agrochemicals, and other fine chemicals. Its unique chemical structure allows it to act as a key intermediate in the synthesis of complex organic molecules.
Used as a Coupling Agent:
In the field of organic chemistry, Toluene-4-sulfonic acid 1-acetyl-piperidin-4-yl ester is utilized as a coupling agent. It facilitates the formation of chemical bonds between molecules, which is crucial in the synthesis of various compounds.
Used in the Preparation of Esters and Ethers:
Toluene-4-sulfonic acid 1-acetyl-piperidin-4-yl ester serves as an intermediate in the preparation of esters and ethers. These functional groups are essential in the creation of a wide range of organic compounds with diverse applications.
Used in the Manufacture of Dyes and Pigments:
This chemical compound is also employed in the production of dyes and pigments. Its ability to form stable complexes with other molecules makes it a valuable component in the creation of colorants for various applications.
Used in the Production of Industrial Products:
Toluene-4-sulfonic acid 1-acetyl-piperidin-4-yl ester finds use in the manufacture of various industrial products. Its versatility and reactivity contribute to the development of innovative materials and compounds for different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 92531-11-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,5,3 and 1 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 92531-11:
(7*9)+(6*2)+(5*5)+(4*3)+(3*1)+(2*1)+(1*1)=118
118 % 10 = 8
So 92531-11-8 is a valid CAS Registry Number.
92531-11-8Relevant academic research and scientific papers
KINASE INHIBITORS AND METHODS OF USE
-
Page/Page column 84-85, (2010/04/03)
The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases such as mTor, tyrosine kinases, and/or lipid kinases such as PI3 kinase. Also provided in the present invention are methods of using these compositions to modulate activities of one or more of these kinases, especially for therapeutic applications.
